<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d266">
    <sentence id="DDI-DrugBank.d266.s0" text="In vitro studies have shown CASODEX can displace coumarin anticoagulants, such as warfarin, from their protein-binding sites.">
        <entity id="DDI-DrugBank.d266.s0.e0" charOffset="28-34"
            type="brand" text="CASODEX"/>
        <entity id="DDI-DrugBank.d266.s0.e1" charOffset="49-70"
            type="group" text="coumarin anticoagulant"/>
        <entity id="DDI-DrugBank.d266.s0.e2" charOffset="82-89"
            type="drug" text="warfarin"/>
        <ddi id="DDI-DrugBank.d266.s0.d0" e1="DDI-DrugBank.d266.s0.e0"
            e2="DDI-DrugBank.d266.s0.e1" type="mechanism"/>
        <ddi id="DDI-DrugBank.d266.s0.d1" e1="DDI-DrugBank.d266.s0.e1"
            e2="DDI-DrugBank.d266.s0.e2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d266.s1" text="It is recommended that if CASODEX is started in patients already receiving coumarin anticoagulants, prothrombin times should be closely monitored and adjustment of the anticoagulant dose may be necessary.">
        <entity id="DDI-DrugBank.d266.s1.e0" charOffset="26-32"
            type="brand" text="CASODEX"/>
        <entity id="DDI-DrugBank.d266.s1.e1" charOffset="75-97"
            type="group" text="coumarin anticoagulants"/>
        <entity id="DDI-DrugBank.d266.s1.e2" charOffset="168-180"
            type="group" text="anticoagulant"/>
        <ddi id="DDI-DrugBank.d266.s1.d0" e1="DDI-DrugBank.d266.s1.e0"
            e2="DDI-DrugBank.d266.s1.e1" type="advise"/>
        <ddi id="DDI-DrugBank.d266.s1.d1" e1="DDI-DrugBank.d266.s1.e0"
            e2="DDI-DrugBank.d266.s1.e2" type="advise"/>
    </sentence>
</document>
